Nanodrugs are a new type of drug developed using nanotechnology. Nanodrugs are designed to be more effective than traditional drugs, making them a promising tool in the treatment of a wide range of diseases. Nanodrugs are made of tiny particles, typically between 1 and 100 nanometers in size, which are designed to have particular properties that make them more efficient at targeting cells, tissues, and organs. Nanodrugs are becoming increasingly popular in the treatment of cancer and other chronic diseases, due to their ability to deliver the drugs to the specific site of action and minimize damage to other cells. Nanodrugs are also being developed for the treatment of infectious diseases, as they are able to penetrate through bacterial cell walls and deliver drugs directly to the site of infection. Nanodrugs are made up of various components, such as polymers, lipids, and nanoparticles, which are all designed to work together to achieve the desired therapeutic effect. Nanoparticles are particularly important, as they are responsible for carrying the drug payload and targeting cells. The particles can be designed to have particular properties, such as size, surface charge, and surface chemistry, which can be used to optimize the drug delivery process. Nanodrugs have the potential to revolutionize the way drugs are designed and delivered, making them more effective and less toxic. As research into nanodrugs continues, it is likely that they will play an increasingly important role in the treatment of a wide variety of diseases.
Title : Circumventing challenges in developing CVD graphene coating on mild steel: A disruptive approach to remarkable/durable corrosion resistance
Raman Singh, Monash University-Clayton Campus, Australia
Title : Highlighting recent advancements in electromagnetic field subwavelength tailoring using nanoparticle resonant light scattering and related topics
Michael I Tribelsky, Moscow State University, Russian Federation
Title : The impact of nanomedicine: 30,000 orthopedic nano implants with no failures and still counting
Thomas J Webster, Hebei University of Technology, United States
Title : Logistic-modified mathematical model for tumor growth treated with nanosized cargo delivery system
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Current and future of red and black phosphorus nanomaterials
Hai Feng Ji, Drexel University, United States
Title : Azodye photoaligned nanolayers for liquid crystal: New trends
Vladimir G Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Title : Atomistic simulation of chemical ordering phenomena in nanostructured intermetallics
Rafal Kozubski, Jagiellonian University in Krakow, Poland
Title : The enhanced cytotoxic effect of curcumin on leukemic stem cells via CD123-targeted nanoparticles
Wariya Nirachonkul, Chiang Mai University, Thailand
Title : Efficiency of nanoparticles (Micromage-B) in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine
Title : Innovative method of nanotechnology application in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine